Jan Anders Holgersson
Founder at NovaHep AB
Jan Anders Holgersson active positions
| Companies | Position | Start | End |
|---|---|---|---|
| Karolinska Institutet | Corporate Officer/Principal | - | - |
NovaHep AB
 NovaHep AB Miscellaneous Commercial ServicesCommercial Services NovaHep AB provides stem-cell research for gene therapy of liver diseases. Its main area of focus is the development of biological, individualised blood vessels that can be used to replace non-functioning blood vessels in patients with different types of vascular disease. The company was founded by Suchitra Sumitran-Holgersson and Jan Anders Holgersson in 2005 and is headquartered in Gothenburg, Sweden. | Chairman | 2004-12-31 | - |
| Founder | 2009-11-25 | - | |
| Director/Board Member | 2004-12-31 | - | |
| Chief Tech/Sci/R&D Officer | 2004-12-31 | - | |
| University of Gothenburg | Corporate Officer/Principal | - | - |
Career history of Jan Anders Holgersson
Former positions of Jan Anders Holgersson
| Companies | Position | Start | End |
|---|---|---|---|
Recopharma AB
 Recopharma AB Pharmaceuticals: MajorHealth Technology Recopharma AB is a biotechnology company that develops ophthalmic products based on protein-carbohydrate interactions. It develops a technology that uses mucins, naturally occurring proteins produced by epithelial tissues with many potential applications. The company was founded in 2004 and is headquartered in Huddinge, Sweden | Director/Board Member | 2009-11-24 | - |
| Chief Executive Officer | 2003-12-31 | - | |
| Chief Tech/Sci/R&D Officer | 2003-12-31 | - | |
| Founder | 2009-11-24 | - | |
AbSorber AB
 AbSorber AB Medical SpecialtiesHealth Technology AbSorber AB develops products for allogeneic transplantation. It offers XM-ONE used for enhanced risk assessment before kidney transplantation. The firm also engages in the development of tools in transplantation. The company was founded by Jan Holgersson and Suchitra Sumitran-Holgersson in 1999 and is headquartered in Stockholm, Sweden. | Director/Board Member | 1998-12-31 | - |
| Founder | 1998-12-31 | - |
Training of Jan Anders Holgersson
| University of Gothenburg | Doctorate Degree |
Statistics
International
| Sweden | 6 |
Operational
| Director/Board Member | 3 |
| Founder | 3 |
| Chief Tech/Sci/R&D Officer | 2 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 3 |
|---|---|
AbSorber AB
AbSorber AB Medical SpecialtiesHealth Technology AbSorber AB develops products for allogeneic transplantation. It offers XM-ONE used for enhanced risk assessment before kidney transplantation. The firm also engages in the development of tools in transplantation. The company was founded by Jan Holgersson and Suchitra Sumitran-Holgersson in 1999 and is headquartered in Stockholm, Sweden. | Health Technology |
Recopharma AB
Recopharma AB Pharmaceuticals: MajorHealth Technology Recopharma AB is a biotechnology company that develops ophthalmic products based on protein-carbohydrate interactions. It develops a technology that uses mucins, naturally occurring proteins produced by epithelial tissues with many potential applications. The company was founded in 2004 and is headquartered in Huddinge, Sweden | Health Technology |
NovaHep AB
NovaHep AB Miscellaneous Commercial ServicesCommercial Services NovaHep AB provides stem-cell research for gene therapy of liver diseases. Its main area of focus is the development of biological, individualised blood vessels that can be used to replace non-functioning blood vessels in patients with different types of vascular disease. The company was founded by Suchitra Sumitran-Holgersson and Jan Anders Holgersson in 2005 and is headquartered in Gothenburg, Sweden. | Commercial Services |
